Compare Gerdau S.A. Common Stock (GGB) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gerdau S.A. Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Gerdau S.A. Common Stock trades at $5.07 (market cap $9.16B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.7 (market cap $2.27B). The key difference: Gerdau S.A. Common Stock is far larger — about 4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Gerdau S.A. Common Stock pays a 3.67% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| GGB | SLS | |
|---|---|---|
Market Cap | $9.16B | $2.27B |
Volume | 16,238,936 | 4,179,659 |
Sector | Basic Materials | Health |
52-Week High | $5.17 | $15.46 |
52-Week Low | $3.15 | $1.39 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $11.10B | $2.14B |
Dividend Yield | 3.67% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gerdau S.A. Common Stock
Gerdau is a steel producer with operations across the Americas. It makes long steel, specialty steel, and other products for construction and industrial markets.
Read more on GGB →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
